Exagen Studies COVID Effects
LIFE SCIENCE: Co. Collaborating With Emory
⯀ By NATALLIE ROCHA
FRONT PAGE
Exagen Inc. (Nasdaq: XGN), a commercial-stage life science company, is joining forces with Emory University to conduct a new study on the long-term effects of COVID-19 infection in the development of autoimmune diseases. The public company announced...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.